Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
24
RGC Quote, Financials, Valuation and Earnings
Last price:
$23.22
Seasonality move
:
-10.21%
Day range:
$23.61 - $25.53
52-week range:
$0.25 - $83.60
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
989.66x
Volume:
89.6K
Avg. volume:
151.4K
1-year change:
22209.6%
Market cap:
$11.5B
Revenue:
--
EPS (TTM):
-$0.33
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Regencell Bioscience Holdings Ltd. has -- downside to fair value with a price target of -- per share.
RGC vs. S&P 500
-
Over the past 5 trading days, Regencell Bioscience Holdings Ltd. has underperformed the S&P 500 by -1.04% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Regencell Bioscience Holdings Ltd. does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Regencell Bioscience Holdings Ltd. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Regencell Bioscience Holdings Ltd. reported revenues of --.
Earnings Growth
-
Regencell Bioscience Holdings Ltd. has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Regencell Bioscience Holdings Ltd. reported earnings per share of --.
Enterprise value:
6.6B
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
-0.26x
EV / Free cash flow:
-8,661.33x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2024-03-14 | 2025-03-14 | 2025-03-14 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $66.9K | $16.4M | $11.6M | $8.1M | -- | |
| Total Assets | $340.1K | $18M | $12.6M | $8.4M | -- | |
| Current Liabilities | $4.3M | $577.8K | $606.9K | $193.6K | -- | |
| Total Liabilities | $4.3M | $938K | $632.3K | $219.5K | -- | |
| Total Equity | -$4M | $17.1M | $12M | $8.2M | -- | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2024-03-14 | 2025-03-14 | 2025-03-14 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
RGC
Sector
Market Cap
$11.5B
$25.1M
Price % of 52-Week High
27.79%
48.72%
Dividend Yield
0%
0%
Shareholder Yield
--
-1.6%
1-Year Price Total Return
6165.02%
-18.38%
Beta (5-Year)
--
0.490
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$24.65
200-day SMA
Buy
Level
$19.76
Bollinger Bands (100)
Buy
Level
13.96 - 30.52
Chaikin Money Flow
Buy
Level
775.1M
20-day SMA
Sell
Level
$27.11
Relative Strength Index (RSI14)
Sell
Level
43.05
ADX Line
Sell
Level
15.84
Williams %R
Neutral
Level
-64.1509
50-day SMA
Sell
Level
$28.92
MACD (12, 26)
Sell
Level
-1.13
25-day Aroon Oscillator
Sell
Level
-60
On Balance Volume
Neutral
Level
2.4B
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (5639.4755)
Sell
CA Score
(Annual)
Level (-0.9256)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (7.4697)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.
Stock Forecast FAQ
In the current month, RGC has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The RGC average analyst price target in the past 3 months is --.
-
Where Will Regencell Bioscience Holdings Ltd. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Regencell Bioscience Holdings Ltd. share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Regencell Bioscience Holdings Ltd.?
Analysts are divided on their view about Regencell Bioscience Holdings Ltd. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Regencell Bioscience Holdings Ltd. is a Sell and believe this share price will rise from its current level to --.
-
What Is Regencell Bioscience Holdings Ltd.'s Price Target?
The price target for Regencell Bioscience Holdings Ltd. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is RGC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Regencell Bioscience Holdings Ltd. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of RGC?
You can purchase shares of Regencell Bioscience Holdings Ltd. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Regencell Bioscience Holdings Ltd. shares.
-
What Is The Regencell Bioscience Holdings Ltd. Share Price Today?
Regencell Bioscience Holdings Ltd. was last trading at $23.22 per share. This represents the most recent stock quote for Regencell Bioscience Holdings Ltd.. Yesterday, Regencell Bioscience Holdings Ltd. closed at $23.66 per share.
-
How To Buy Regencell Bioscience Holdings Ltd. Stock Online?
In order to purchase Regencell Bioscience Holdings Ltd. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get RGC Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
RGC
Sector
P/E ratio
--
21.37x
PEG ratio
-0.26x
-0.01x
P/B ratio
989.66x
1.73x
Price / LTM sales
--
1.46x
Growth Metrics
RGC
Sector
Revenue growth
--
3.27%
Earnings growth
--
12.13%
Revenue (5-year growth)
--
6.25%
Earnings forecast
--
-$0.20
Profitability
RGC
Sector
Profitability FY 2025
-$392.7K
$2.3M
Return on invested capital
--
-33.43%
Return on assets
--
-29.94%
Return on equity
--
-40.07%
Earnings Date
Last Earnings Date
Nov
18
Next Earnings Date
Jun
2
Estimated Next Earnings Date
Feb
17
Balance Sheet
RGC
Sector
Total cash
$8M
$24.9M
Short term investments
$5M
$23M
Total assets
$5.8M
$70.1M
Long term debt
--
$2.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 37x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 34x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
92
APEI alert for Mar 13
American Public Education, Inc. [APEI] is up 26.24% over the past day.
Buy
52
PZZA alert for Mar 13
Papa John's International, Inc. [PZZA] is down 5.25% over the past day.
Buy
53
NBIS alert for Mar 13
Nebius Group NV [NBIS] is up 0.87% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
